Product Details for ANDA 213096
PROPAFENONE HYDROCHLORIDE (PROPAFENONE HYDROCHLORIDE)
225MG
Marketing Status: Prescription
325MG
Marketing Status: Prescription
425MG
Marketing Status: Prescription
225MG
Marketing Status: Prescription
Active Ingredient: PROPAFENONE HYDROCHLORIDE
Proprietary Name: PROPAFENONE HYDROCHLORIDE
Dosage Form; Route of Administration: CAPSULE, EXTENDED RELEASE; ORAL
Strength: 225MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A213096
Product Number: 001
Approval Date: Feb 21, 2023
Applicant Holder Full Name: AUROBINDO PHARMA LTD
Marketing Status: Prescription
Patent and Exclusivity Information
PROPAFENONE HYDROCHLORIDE (PROPAFENONE HYDROCHLORIDE)
Proprietary Name: PROPAFENONE HYDROCHLORIDE
Dosage Form; Route of Administration: CAPSULE, EXTENDED RELEASE; ORAL
Strength: 225MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A213096
Product Number: 001
Approval Date: Feb 21, 2023
Applicant Holder Full Name: AUROBINDO PHARMA LTD
Marketing Status: Prescription
Patent and Exclusivity Information
325MG
Marketing Status: Prescription
Active Ingredient: PROPAFENONE HYDROCHLORIDE
Proprietary Name: PROPAFENONE HYDROCHLORIDE
Dosage Form; Route of Administration: CAPSULE, EXTENDED RELEASE; ORAL
Strength: 325MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A213096
Product Number: 002
Approval Date: Feb 21, 2023
Applicant Holder Full Name: AUROBINDO PHARMA LTD
Marketing Status: Prescription
Patent and Exclusivity Information
PROPAFENONE HYDROCHLORIDE (PROPAFENONE HYDROCHLORIDE)
Proprietary Name: PROPAFENONE HYDROCHLORIDE
Dosage Form; Route of Administration: CAPSULE, EXTENDED RELEASE; ORAL
Strength: 325MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A213096
Product Number: 002
Approval Date: Feb 21, 2023
Applicant Holder Full Name: AUROBINDO PHARMA LTD
Marketing Status: Prescription
Patent and Exclusivity Information
425MG
Marketing Status: Prescription
Active Ingredient: PROPAFENONE HYDROCHLORIDE
Proprietary Name: PROPAFENONE HYDROCHLORIDE
Dosage Form; Route of Administration: CAPSULE, EXTENDED RELEASE; ORAL
Strength: 425MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A213096
Product Number: 003
Approval Date: Feb 21, 2023
Applicant Holder Full Name: AUROBINDO PHARMA LTD
Marketing Status: Prescription
Patent and Exclusivity Information
Proprietary Name: PROPAFENONE HYDROCHLORIDE
Dosage Form; Route of Administration: CAPSULE, EXTENDED RELEASE; ORAL
Strength: 425MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A213096
Product Number: 003
Approval Date: Feb 21, 2023
Applicant Holder Full Name: AUROBINDO PHARMA LTD
Marketing Status: Prescription
Patent and Exclusivity Information